SCHEMBL26146349

SCHEMBL26146349

CC(C)(C)OC(=O)N1CCN(c2nc(Cc3ccccc3)co2)CC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.52
▸ CKS1B P61024 2/20 0.48
▸ SKP1 P63208 2/20 0.48
▸ SKP2 Q13309 2/20 0.48
▸ PRMT5 O14744 1/20 0.45
▸ STS P08842 1/20 0.45
▸ GRIA1 P42261 2/20 0.44
▸ GPR119 Q8TDV5 3/20 0.44
▸ SCD O00767 1/20 0.44
▸ SCD5 Q86SK9 1/20 0.44
▸ ABCB1 P08183 1/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GBA1 P04062 1/20 0.43
▸ PTPN11 Q06124 1/20 0.43
▸ SLC2A1 P11166 1/20 0.43
▸ ACKR3 P25106 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764612 0.81 CKS1B (0.56) ACHECKS1BSKP1SKP2GPR119
SCHEMBL25178650 0.79 ACHE (0.53) ACHECKS1BSKP1SKP2STS
SCHEMBL25419563 0.79 CKS1B (0.49) ACHECKS1BSKP1SKP2GPR119
SCHEMBL17373792 0.78 CKS1B (0.46) ACHECKS1BSKP1SKP2GPR119
SCHEMBL14990872 0.78 CKS1B (0.46) ACHECKS1BSKP1SKP2GPR119
SCHEMBL26146347 0.77 CKS1B (0.47) ACHECKS1BSKP1SKP2GPR119
SCHEMBL26094150 0.77 CKS1B (0.43) ACHECKS1BSKP1SKP2GPR119
SCHEMBL2881674 0.77 GPR119 (0.61) ACHECKS1BSKP1SKP2GPR119
SCHEMBL713180 0.75 GPR119 (0.61) ACHECKS1BSKP1SKP2GPR119
SCHEMBL25172068 0.74 GPR119 (0.56) ACHECKS1BSKP1SKP2GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081923-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Frequency Therapeutics, Inc. (US) 2023-05-11 — — WO disclosed
Send feedback